No products in the cart.
-
Co-amoxiclav Moxiclav 315.5MG/5ML
Co-amoxiclav is indicated for the treatment of the following infections in adults and children: Acute bacterial sinusitis (adequately diagnosed), Acute otitis media, Acute exacerbations of chronic bronchitis (adequately diagnosed), Community acquired pneumonia, Cystitis, Pyelonephritis, Skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis, Bone and joint infections, in particular osteomyelitis
20,000UGXCo-amoxiclav Moxiclav 315.5MG/5ML
20,000UGX -
Co-amoxiclav Moxiclav 156.25MG/5ML SUSPENSION
Co-amoxiclav is indicated for the treatment of the following infections in adults and children: Acute bacterial sinusitis (adequately diagnosed), Acute otitis media, Acute exacerbations of chronic bronchitis (adequately diagnosed), Community acquired pneumonia, Cystitis, Pyelonephritis, Skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis, Bone and joint infections, in particular osteomyelitis
19,000UGX -
Co-amoxiclav Clavulin 228/5ML SUSPENSION
Co-amoxiclav is indicated for the treatment of the following infections in adults and children: Acute bacterial sinusitis (adequately diagnosed), Acute otitis media, Acute exacerbations of chronic bronchitis (adequately diagnosed), Community acquired pneumonia, Cystitis, Pyelonephritis, Skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis, Bone and joint infections, in particular osteomyelitis.
24,000UGXCo-amoxiclav Clavulin 228/5ML SUSPENSION
24,000UGX